Rp. Coppes et al., HETEROGENEITY OF PREJUNCTIONAL NEUROPEPTIDE-Y RECEPTORS INHIBITING NORADRENALINE OVERFLOW IN THE PORTAL-VEIN OF FREELY MOVING RATS, European journal of pharmacology, 261(3), 1994, pp. 311-316
The effects of intraportal infusions of different doses of neuropeptid
e Y, its selective neuropeptide Y Y-1 receptor analogue, [Leu(31),Pro(
34)]neuropeptide Y, and the Y-2-selective C-terminal fragment, neurope
ptide Y-(18-36), on basal and electrically evoked noradrenaline overfl
ow in the portal vein as well as on mean arterial pressure and heart r
ate were investigated in permanently instrumented freely moving rats.
Neuropeptide Y dose dependently (2-2000 ng/kg/min) attenuated the elec
trically evoked noradrenaline overflow and almost complete blockade wa
s reached at the highest dose used. [Leu(31),Pro(34)]Neuropeptide Y al
so dose dependently (20-20000 ng/kg/min) attenuated the evoked overflo
w, reaching a maximum of 55% inhibition at the highest dose (20000 ng/
kg/min). Neuropeptide Y-(18-36) attenuated the evoked release only at
20000 ng/kg/min (by 46%). Only at the highest dose did neuropeptide Y
(2000 ng/kg/min) and [Leu(31),Pro(34)]neuropeptide Y (20000 ng/kg/min)
significantly enhance mean arterial pressure and decrease heart rate
and basal plasma noradrenaline levels, the latter two effects being du
e to the baroreceptor reflex. Neuropeptide Y-(18-36) did not influence
these parameters at all doses used. The results indicate the presence
of prejunctional neuropeptide Y Y-1 receptors, and possibly the coexi
stence of Y-1 and Y-2 receptors, in the portal vein of freely moving r
ats, which in conjunction are able to inhibit markedly electrically ev
oked noradrenaline overflow. Postjunctional neuropeptide Y receptors m
ediating an increase in blood pressure in the freely moving rat are so
lely of the Y-1 subtype.